Interview with Sarabjit Kour Nangra, VP Research - IT, Angel Broking Faraan Tarique | Mumbai January 9, 2015 Last Updated at 16:00 IST Analysts are quite impressed by third-quarter results from Infosys as it turned out to be better than what they had ... Business Standard, 1 month ago
Infosys PAT higher than our expectations: Sarabjit Kour Nangra, Angel Broking - Economic Times, 1 month ago
1 images for "sarabjit kour nangra"
NEW DELHI: Sun Pharmaceuticals surged over 8 per cent in intraday trade to hit its 52-week high of Rs 1,006 after the drug maker said it would acquire the opiates business of British drug maker GlaxoSmithKline (GSK) in Australia, in a bid to capture ...Economic Times, 1 day ago Sun Pharma hits fresh 52-week high, up nearly 7% on plans to buy GSK unit Economic Times, 1 day ago
Mumbai, March 3: Sun Pharmaceutical Industries today announced that it was acquiring the opiates business of GlaxoSmithKline (GSK) in Australia for an undisclosed amount. The acquisition is part of the Dilip Shanghvi-led company's plan to improve ...Calcutta Telegraph, 2 days ago Sun Pharma in pact to buy GSK's opiates business in Australia Livemint.com, 2 days ago Sensex volatile, Midcap outperforms; Reliance, TCS rally Moneycontrol.com, 2 days ago
Lupin has been in the midst of news flow. While last week it announced developments on two respiratory products, on Monday it received final approval from USFDA to market generic version of Allergan Inc.'s Lumigan, an ophthalmic solution. The ...Business Standard India, 1 week ago Lupin's Pithampur unit under US FDA lens DNA India, 1 week ago Lupin says FDA raises concerns over Pithampur plant Livemint.com, 1 week ago
Mumbai, Feb. 16: Infosys will acquire US-based automation technology company Panaya for $200 million (over Rs 1,200 crore). The all-cash deal is the second-largest acquisition for the Bangalore-based firm, after Swiss consulting company ...Calcutta Telegraph, 2 weeks ago Infosys buys automation technology firm Panaya The Financial Chronicle, 2 weeks ago Infosys buys US-based Panaya for $200 million Oneindia, 2 weeks ago Infosys to buy automation tech firm Panaya for $200 mn Business Standard India, 2 weeks ago
Mumbai,Feb. 10: IT-BPO exports are likely to grow at 12-14 per cent in the next fiscal, industry body Nasscom said today. The growth rate is lower than the 13-15 per cent guidance for this year. The slower growth projection has been attributed to ...Calcutta Telegraph, 3 weeks ago
According to Nasscom, revenues for IT sector are expected to grow at 13% in FY2015 to end the year, USD 146 billion. The revenue growth rate target stands at 13.1% in constant currency terms and 13.9% in rupee terms, the industry body said. The ...MyIris, 3 weeks ago
Questions raised over integrity of clinical research data at a site operated by GVK Biosciences BS Reporter | Hyderabad February 3, 2015 Last Updated at 13:08 IST Several drugs manufactured and marketed by as many as seven Indian generic ...Business Standard India, 1 month ago Drugs of seven Indian pharma firms in EMA's suspension list Smart Investor, 1 month ago Drugs of 7 Indian pharma firms in EMA's suspension list Rediff.com, 4 weeks ago
Mumbai, Jan. 30: Tech Mahindra today announced a 1:1 bonus issue while splitting its stock in the ratio of 2:1 (two equity shares of Rs 5 each for every one equity share of Rs 10 each), offering a double bonanza to its investors. This is the ...Calcutta Telegraph, 1 month ago
NEW DELHI: Ranbaxy Laboratories has lost the opportunity to exclusively market in the United States for six months the first generic version of Anglo Swedish drug innovator Astra Zeneca's heartburn drug Nexium, the Delhi-based company said in a ...Times of India, 1 month ago Ranbaxy Laboratories : forfeits 180 days exclusivity for generic Nexium 4 Traders, 1 month ago
on your WebpageAdd Widget >Get your members hooked!